News

New ASM data show indoor environments are associated with quick and frequent pathogen contamination of the common respiratory device.

Because the number of children hospitalized with COVID-19 is so low, facilities should ensure clinical data is easily available and shared across healthcare platforms.

EVD outbreaks this year serve as a reminder of the virus’ severity and the importance of having a containment strategy in place.

Children infected with SARS-CoV-2 who are Black, Hispanic or Asian have a greater risk of developing the rare multisystem inflammatory syndrome, a new study found.

The device may help clinicians differentiate between past infections and co-infections during the upcoming flu season.

Greater disease severity was associated with low executive functioning.

According to a small study, the Moderna and Pfizer COVID-19 vaccines do not impact male fertility.

Examining pharmacological management in COVID-19 patients with ARDS requiring antifungal therapy during extracorporeal life support.

The course of COVID-19 illness was likely to be less severe than of influenza in a study of hospitalized children.

New findings on an available 15-minute test show an approximate 81% sensitivity in detection of SARS-CoV-2.

New findings from the ASM 2021 World Microbe Forum suggest the emergency-authorized platform can capably detected the highly transmissible UK-borne variant.

Investigators looked at data from 3 analyses showed a reduction in mortality was observed across a spectrum of baseline oxygen requirements, at different timeframes, over the course of the pandemic, and in various geographies.

Africa sees third wave as only 1% of the population is fully vaccinated.

The recombinant human IgG1κ monoclonal antibody binds and neutralizes the virus.

A study paired long-term care facilities (LTCF) staff who were recovered with susceptible residents to help reduce transmission. The goal was simple: pair those susceptible staff and residents with those who were recovered and felt to have protective immunity.

EUAs can enable people to get immediate access to preventive therapy or treatment, but is it always worth aiming for full approval?

Modeling studies highlight best approaches for schools in the coming academic year.

QPX9003 was developed through an NIAID-supported drug discovery collaboration with world experts.

CVnCoV demonstrated an interim vaccine efficacy of 47% against COVID-19 disease of any severity.

Investigators in Brazil attribute Trichosporon asahii fungemia in critically ill COVID-19 patients to “overexposure” to antibiotics and corticosteroids.

A discussion surrounding Novavax’s NVX-CoV2373 with Lisa Dunkle, MD.

Individuals with 3 or more comorbid conditions took longer for a negative SARS-CoV-2 PCR test result.

Multi-system inflammatory syndrome in children (MIS-C), is thought to affect 1 in 50,000 children with SARS-CoV-2 infection.

Social factors associated with viral spread could be useful for pinpointing areas that need public health interventions.

Contact tracing can be an effective tool for identifying new cases of COVID-19, but a new study found that close contacts were reported for only about a third of laboratory confirmed cases.

The SARS-CoV-2 virus was seen to be circulating as early as December of 2019.

Rhinoviruses have been shown to protect against influenza, can they also help with SARS-COV-2?

A balance disruption between pro-clotting and anti-clotting molecules drive the blood clotting.

Regeneron’s monoclonal antibodies, casirivimab and imdevimab (REGEN-COV), reduced risk of death by 20% in patients hospitalized with COVID-19 who had not mounted their own immune response.